1. Home
  2. BWMN vs CAPR Comparison

BWMN vs CAPR Comparison

Compare BWMN & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowman Consulting Group Ltd.

BWMN

Bowman Consulting Group Ltd.

N/A

Current Price

$42.91

Market Cap

508.6M

ML Signal

N/A

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

N/A

Current Price

$7.09

Market Cap

584.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BWMN
CAPR
Founded
1995
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
508.6M
584.9M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
BWMN
CAPR
Price
$42.91
$7.09
Analyst Decision
Hold
Buy
Analyst Count
5
10
Target Price
★ $43.00
$27.00
AVG Volume (30 Days)
336.3K
★ 2.6M
Earning Date
11-17-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 329.41
N/A
EPS
★ N/A
N/A
Revenue
★ $490,017,000.00
N/A
Revenue This Year
$21.26
N/A
Revenue Next Year
$18.02
$1.52
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.88
N/A
52 Week Low
$25.07
$2.96
52 Week High
$45.00
$40.37

Technical Indicators

Market Signals
Indicator
BWMN
CAPR
Relative Strength Index (RSI) 77.93 51.07
Support Level $42.39 $6.01
Resistance Level $43.14 $10.73
Average True Range (ATR) 0.06 0.54
MACD -0.07 0.11
Stochastic Oscillator 84.09 90.20

Price Performance

Historical Comparison
BWMN
CAPR

About BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: